About
Embolx, Inc. is a medical device company based in Silicon Valley, California, founded in 2013. The company specializes in developing advanced microcatheters for arterial embolization procedures, aiming to enhance treatments for conditions like cancerous tumors, benign prostatic hyperplasia, and uterine fibroids. Their flagship product, the Sniper® Balloon Occlusion Microcatheter, utilizes pressure regulation technology to allow precise control of blood flow. This innovation improves drug distribution within tumors while minimizing exposure to surrounding healthy tissues, leading to better therapeutic outcomes and fewer side effects compared to traditional methods. Embolx targets hospitals and physician offices that focus on interventional radiology and oncology, providing tools designed to improve the precision and safety of embolization procedures. The company is privately held and has garnered investment from various venture capital firms, supported by a leadership team with extensive experience in medical devices and diagnostics.
Technologies
Keywords
Company Information
- Employees15
- Founded2013
- Total Funding$3629000
Location
530 Lakeside Dr, Sunnyvale, California, United States, 94085-4055
